The AI trade cuts both ways: Astera and Keel rip while Accenture logs its worst day since 2001

1

BF

Butterfly Network $BFLYBullish sentiment

Butterfly's quietest name turned into the week's loudest hardware story. On June 18, Midjourney — yes, the AI image lab — launched "Midjourney Medical," a full-body "ultrasonic CT" scanner built around 40 of Butterfly's Ultrasound-on-Chip modules, riding an existing supply deal worth up to $74M over five years. Shares ripped roughly 52% toward four-year highs on about 43M shares; 731 posts chased it.

The crowd is unreservedly bullish, casting $BFLY as "the eyes" of Midjourney's medical pivot and doing the arithmetic on 50,000 scanners planned over six years.

The income statement is still early-stage: Q1 revenue grew 25% to $26.5M at a -51% operating margin, and the stock now sits in the 99.5th percentile of its range on a 12.85x volume multiple. One off note — CCO Steve Cashman sold $1.9M on June 5 and 8, days before the announcement made the timing look unfortunate.

2

LE

Centrus Energy $LEUBullish sentiment

Centrus jumped double digits after signing a June 18 letter of intent to supply Oklo with domestic HALEU — enough to feed up to five Aurora powerhouses from its Piketon, Ohio plant, with deliveries starting in 2029. It's the commercial anchor the bull case had been waiting on, and mentions climbed 52% on the day.

The conversation leans hard on the "only US-licensed HALEU enricher" monopoly framing, pairing the Oklo deal with a roughly $2.8B effective war chest against a ~$3.6B market cap.

The same 8-K quietly refreshed a poison pill to protect the company's NOL tax assets — board-level signaling worth filing away. Q1 backed the optimism modestly: revenue of $76.7M up ~5%, EPS of $0.51 against $0.33 expected. The caveats are real — the LOI is non-binding, and the stock still trades below its 200-day.

3

KE

Keel Infrastructure $KEELBullish sentiment

Keel — a Bitfarms spinout pivoting from bitcoin mining toward AI data centers and the on-site power to run them — pulled 2,220 posts as three catalysts stacked up the same week: all three flagship campuses cleared zoning, a $458M convertible priced at a 25% premium, and Russell 3000 inclusion confirmed for June 29.

Bulls are modeling paths well into double digits on the 2.2GW pipeline and pointing to dark-pool prints and lopsided large-order inflows. The recurring caveat in the replies: the stock has been rejected at $6 five separate times.

The data complicates the narrative. Revenue actually fell 45% year-over-year to $37M as the mining base unwound during the pivot, yet the name is up 707% over twelve months — squarely deal-and-story territory. The entire thesis rests on one event that hasn't happened: the first hyperscaler lease.

4

SN

Snowflake $SNOWBullish sentiment

Snowflake came back into focus across 1,948 posts as a clean software-pullback setup, helped by an unusually candid CEO moment: Sridhar Ramaswamy named AI coding agents — Anthropic specifically — as a bigger long-term threat than AWS or Azure, a frame the market oddly rewarded. A Zeta partnership and flagged insider buying added kindling.

Traders are circling the $239-$250 zone for a breakout and citing heavy bullish LEAP flow; the bear retort is simply Databricks, whose SQL business has more than doubled to $1.5B ARR.

The numbers are improving under Ramaswamy — Q1 FY27 revenue grew 33.5% to $1.39B, a third straight quarter of re-acceleration — though GAAP operating margin is still -23%. One thing to weigh against the optimism: Frank Slootman trimmed $1.9M of stock on June 16.

5

AL

Astera Labs $ALABBullish sentiment

Astera Labs printed an all-time high near $421 on June 18, days ahead of its June 22 entry into the Nasdaq-100 — and that forced passive buying from QQQ and its peers is the dominant near-term driver. The feed tracked it across 2,224 posts.

The bull voice is close to unanimous here; even one trader who admitted "losing conviction" conceded the stock just kept printing. Posts dwell on the connectivity-chip moat in PCIe fabrics and switches and an 81% forward-growth figure.

The fundamentals are sprinting to keep pace — Q1 revenue rose 93% to $308M at a 76% gross margin and 22% operating margin. The honest counter-signal sits in the Form 4s: directors Jack Lazar and Stefan Dyckerhoff sold a combined ~$8M into the breakout in early June, right around $355-$365.

6

AC

Accenture plc $ACNBearish sentiment

Accenture supplied the week's blow-up. The Q3 print actually beat on revenue and EPS ($3.80, up 9%), but new bookings fell 2% and the Q4 guide of $17.75-$18.40B landed under the $18.47B consensus — enough to drop shares ~18%, the worst single day since the 2001 IPO. Mentions more than doubled.

The bearish read ran the table: the chatter casts Accenture's 80,000-plus consultants as the workforce most exposed to AI agents eating consulting workflows — "AI fails to magically transform their business," as one post framed it.

The pushback is valuation. After a 52% slide year-to-date into the bottom ~1% of its range, the stock trades under 10x earnings with a 4-6% dividend yield and a real TAM in AI-deployment consulting. The unresolved question is whether bookings stabilize before the multiple compresses further.

7

SA

Strive, Inc. Series A Perpetual Preferred $SATABullish sentiment

Strive's $SATA — a 13% variable-rate perpetual preferred that anchors the company's new "digital credit" product — drew 928 posts after printing its first close at par ($100) since late May, on sustained daily volume of $77-98M.

Bulls frame it as a novel yield instrument finding traction, citing roughly 300 BTC a day being accumulated as the ATM window reopens. Skeptics counter that perpetual preferreds aren't risk-free and that $SATA could eventually drift to a discount, the way Strive's earlier STRC paper did.

Under the hood, parent Strive holds 19,105 BTC and $141M in reserves with zero debt, and the board reaffirmed the 13% rate effective July 1. The structural question is durability — whether par holds, and whether 13% on perpetual paper survives a sharp move in rates or in bitcoin itself.

8

TM

TransMedics Group $TMDXBullish sentiment

TransMedics trended on operating data rather than a press release: across 1,552 posts, the crowd flagged its organ-transport fleet averaging 36-plus flights a day in June, up 40% year-over-year and 17% month-over-month, and modeled roughly $200M of Q2 revenue against a $184M street estimate.

The tone is constructive-turnaround, with European airline expansion and softer jet-fuel costs cited as margin tailwinds.

The reported figures still lag the flight log: Q1 revenue grew 21% to $174M, but operating margin compressed to 7.6% on fleet build-out costs and EPS missed by 51%. The stock is down 36% both year-to-date and over twelve months, in the bottom fifth of its range — and class-action firm Johnson Fistel is poking at the margin-pressure disclosures. The flights and the income statement haven't reconciled yet.

9

IN

Inter & Co $INTRBullish sentiment

Inter & Co was the week's deep-value oddity — only 112 posts, but a name fintwit keeps circling as one of the cheapest LatAm fintechs at roughly 9x earnings and 1.3x book. The fresh hook: the Brazilian bank opened its first US branch in Miami on June 8, exactly the diversification step bulls had been asking for.

The argument is tidy — 28% growth and a multi-product platform trading like distressed paper, with US expansion and product cross-sell as the re-rating levers.

The tape disagrees for now. The stock sits in the bottom 0.4% of its 52-week range, 34% below its 200-day on light volume — that's distribution, not a base. Q1 revenue did grow 40% to BRL 4.22B at an 11% margin, but banking is still 87% of the mix, leaving cross-sell as a long-cycle proof point.

10

SH

Seanergy Maritime Holdings $SHIPBullish sentiment

Seanergy Maritime touched all-time highs across 294 posts as Capesize freight-forward agreements ticked up 1-2% and the Capesize segment outran the broader dry-bulk index. With a float of only ~14M shares, the smallest listed Capesize operator feels every wiggle in rates first.

Bulls are watching for a close above key levels and pointing to a fourth straight earnings beat; the draw is leverage, and so is the risk — the same float cuts both ways on a gap.

The fundamentals are welded to the rate cycle: Q1 revenue rose ~77% to $42.9M with operating margin above 27% and EPS of $0.63 beating $0.39 by 62%. Sell-side modeling near $3.35 of FY26 EPS depends entirely on Capesize rates holding — a Brazilian iron-ore slowdown or an Australian weather reversal would deflate it quickly.